Conditions: PTCL; Refractory
Interventions: Drug: Zeprumetostat+Azacitadine; Drug: Zeprumetostat+Decitabine; Drug: Zeprumetostat+Chidamide; Drug: Zeprumetostat+Golidocitinib
Sponsors: Ruijin Hospital
Not yet recruiting Conditions: PTCL; Refractory
Interventions: Drug: Zeprumetostat+Azacitadine; Drug: Zeprumetostat+Decitabine; Drug: Zeprumetostat+Chidamide; Drug: Zeprumetostat+Golidocitinib
Sponsors: Ruijin Hospital
Not yet recruiting
